I95.2
Conditions
Interventions
Group 1: Control group - anesthesia induction in supine position - standard monitoring including CNAP monitoring
Group 2: Intervention group - anesthesia induction in supine position with Passive Leg
Sponsors
Klinik für Anästhesiologie und Operative Intensivmedizin, UNIVERSITÄTSKLINIKUM Schleswig-Holstein, Campus Kiel
Eligibility
Sex/Gender
All
Age
45 Years to No maximum
Inclusion criteria
Inclusion criteria: - elective surgery under general anesthesia (total intravenous or balanced general anesthesia) with the induction drugs sufentanil, propofol and rocuronium - ASA status I, II or III - Patient consent
Exclusion criteria
Exclusion criteria: - Marked edema or skin defects on the patient's fingers or hand - Heart failure (New York Heart Association (NYHA) stage II or greater) - Atrial fibrillation or other higher-grade cardiac arrhythmia - peripheral arterial disease (Fontaine stage > 2) - central regional anesthesiology procedures - suspected or documented difficult airway - induction of anesthesia as "rapid sequence induction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recording of differences in mean arterial blood pressure (MAP) readings in the control and intervention groups during the study period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Capture of the incidence of cumulative time (= minutes of severe hypotension (MAP < 65 mmHg)) within the study period in the control and intervention groups. 2. Determination of the time-weighted mean value of MAP below threshold (< 65 mmHg) within the study period in the control and intervention groups. 3. Pointing out the difference in the absolute dose of vasopressors administered in the control and intervention groups within the study period. | — |
Countries
Germany
Contacts
Public ContactUlf Lorenzen
Klinik für Anästhesiologie und Operative Intensivmedizin, UNIVERSITÄTSKLINIKUM Schleswig-Holstein, Campus Kiel
Outcome results
None listed